New energy and new medical reform policies benefited, and the new shares were weakly active again

The new energy plan draws further attention: Media Disclosure The "Twelfth Five-Year Plan" for the development of national strategic emerging industries has entered the consultation stage.

It is understood that during the "12th Five-Year Plan" period, China's new energy industry has locked in four major industries: nuclear power, wind power, solar energy, and biomass energy. In terms of industrial scale planning, there is a large space for nuclear power and wind power, and it is still uncertain. The installed capacity of solar and biomass power generation is relatively certain, that is, over 10 million kilowatts and 13 million kilowatts respectively in the next five years. Among them, the installed capacity of biomass power generation increased by 160% compared with 2010, and this target figure exceeded the installed capacity of photovoltaic power. The low cost of biomass power generation and the high cost of solar power are one of the main reasons that lead to faster development of biomass in the next five years.

New Medical Reform Promotes Medical Devices: The media disclosure of biomedicine “Twelfth Five-Year Plan” is expected to be introduced, and the field of supporting medical devices will become the focus of planning. People in the industry believe that the demand for medical devices in China will increase significantly in the next five years, and related fields are also expected to become investment hotspots. Up to now, China's medical device market has a capacity of 100 billion yuan, the compound annual growth rate is 21%, and the ratio with drugs is 1:10, while the level in developed countries is 1:1, which means that China's medical device market still has Great room for growth. Some analysis pointed out that the state's capital injection to purchase basic equipment is just a beginning. The “new medical reform” will first have a positive impact on low-end medical devices. Since currently China's 60% of medical institutions use medical devices that belong to the mid-1980s, the proportion of medical device consumption in the entire pharmaceutical industry accounts for only 13%, while the international average is 42%. The future of medical machinery will be VC. /PE investment focus.

It is expected that the annual compound annual growth rate of medical devices will be maintained at around 25% in the next five years, far exceeding other industrial fields such as pharmaceutical manufacturing, pharmaceutical commerce and medical services.